Press Releases

ACRO Announces 2023 Officers and New Member

March 6, 2023

WASHINGTON, DC – Washington DC – ACRO is pleased to announce that its Board of Directors has elected Paul Kirchgraber, M.D., Executive…

Press Releases

ACRO Expands Decentralized Clinical Trials Toolkit with Release of Change Management Resource

October 18, 2022

WASHINGTON, DC – Today, the Association of Clinical Research Organizations (ACRO)’s DCT Working Party releases the latest addition to its DCT Toolkit:…


ACRO & TransCelerate Issue a Joint Statement on Considerations while Developing Clinical Study Reports (CSRs)

September 12, 2022

Our member companies have faced widespread clinical trial disruptions in the past few years – from the global pandemic, to the war…

Press Releases

ACRO Releases Diversity and Inclusion Principles Statement in Support of More Diverse Clinical Trials

August 25, 2022

WASHINGTON, DC – This week, the Association of Clinical Research Organizations (ACRO)’s Diversity and Inclusion in Clinical Trials committee is proud to…


OPINION: Keep Our Foot on the Gas for Clinical Trial Diversity

August 8, 2022

The below is an Op-Ed authored by ACRO Chair, Jackie Kent, for MedPage Today on August 6, 2022. Read the full article…


ACRO Congressional Update – ADPPA

July 11, 2022

With bipartisan sponsorship from Representatives Pallone (D-NJ) and McMorris Rodgers (R-WA) the American Data Privacy and Protection Act (ADPPA), which would create…


ACRO Celebrates 20 Years

April 15, 2022

ACRO Celebrates 20 Years! 20 years ago, contract research organizations were still relatively new players within the clinical research enterprise, and the…

Press Releases

ACRO Marks 20th Anniversary – And Welcomes New Member

April 1, 2022

Washington, DC — On March 16, 2022, ACRO’s Board of Directors was joined by more than 125 clinical research stakeholders – including…

Press Releases

2022 Officers and New Member Announcement

January 21, 2022

Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jackie…


OPINION: Clinical Trials in the Spotlight: How to Solidify the Progress Made

November 30, 2021

The below is the Op-Ed authored by ACRO Executive Director, Doug Peddicord for Morning Consult on November 3, 2021. Read the full…


ACRO Releases Toolkit to Help Advance Decentralized Clinical Trials

August 11, 2021

Today, ACRO released its DCT Toolkit, which lays out a vision for how decentralized clinical trials can be planned and executed now…

Press Releases

ACRO Applauds Release of Cures 2.0 Draft Legislation

June 23, 2021

Washington, DC — The Association of Clinical Research Organizations (ACRO) congratulates Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) on the release…

Press Releases

ACRO Releases New Report on the Past, Present, and Future of Risk-Based Monitoring

May 4, 2021

Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial…

Press Releases

2021 Officers and New Member Announcement

December 17, 2020

Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Steve…

COVID-19Lessons Learned

Warping the speed of vaccine development

November 30, 2020

Ironically, the Pfizer-BioNTech Covid-19 vaccine program did not take “Operation Warp Speed” funding. Even more ironic is the fact that Pfizer got…

COVID-19Lessons Learned

A ‘Holy Grail Moment’ for Clinical Research

November 23, 2020

It was a familiar scenario: A rare disease area of oncology. A new drug candidate. A desire to assess efficacy as safely and quickly as possible, so that if successful, a new therapy could get approved and change lives. But this desire could have been tempered by reality: the trial was going to be challenging and slow…

COVID-19Lessons Learned

Seeing progress through the eyes of patients

November 20, 2020

For the clinical research industry, technological tools improve trial continuity, and generate data that helps power more robust monitoring of safety and quality. They can also be a natural fit for patients. IQVIA also sees study participants liking the direct shipment of medicines, telehealth interactions and at-home visits. In the COVID era and beyond, designing more trials with these kinds of technology-enabled strategies is going to help more people by lowering barriers to participation, and speeding the development of new medicines.

COVID-19Lessons Learned

Are we ready for holistic, virtual access?

November 18, 2020

Diverse technology solutions, like patient telehealth visits, accessing electronic medical records (EMRs) or remote source data verification, can generate vast amounts of data. As the clinical research industry evolves towards its next “new normal” with a higher baseline level of remote monitoring, IQVIA is considering the implications of increasing data access. Are we ready?

COVID-19Lessons Learned

Technology solutions: Weathering a storm, helping envision a future

November 16, 2020

We all had a flurry of unprecedented activity. We were assessing risks to patients and data, and putting in place mitigation strategies to preserve continuity of the studies.” Those strategies involved thousands of amendments to protocols, adapting to sudden changes that impacted patients and sites around the world.

COVID-19Lessons Learned

A new fight sees new tools and new challenges

November 2, 2020

A key pillar in the COVID-19 battle is the rapid development of a safe and effective vaccine. As vaccine R&D shifted into gear and then accelerated throughout 2020, with a rapidly growing number of candidates, platforms and manufacturers, it appeared that a bottleneck in this race could actually be the ability to enroll participants.